March 31, 2015

Featured Post

EP Lab Digest Publishes About 2015 Get in Rhythm Atrial Fibrillation Patient Conference

EP Lab Digest recently published 2015 Get in Rhythm Patient Conference: Helping Afib Patients Get in Rhythm and Stay in Rhythm, authored by StopAfib.org founder Mellanie True Hills. The article talks about the previous successful inaugural Get in Rhythm, Stay in Rhythm Atrial Fibrillation Patient Conference, including what participants had to say. We have raised the bar for 2015 by making it a weekend conference and featuring top afib experts from around the US.

To learn more, see: Helping Afib Patients Get in Rhythm and Stay in Rhythm at the 2015 Get in Rhythm Patient Conference

Afib patients from the US, Canada, and the Caribbean will be at the Atrial Fibrillation Patient Conference. Will you?

Are you joining us on March 28-29 in Dallas to learn from our world-renowned afib experts on how to get in rhythm and stay in rhythm? Afib patients are coming from all over to be here, and we hope you can join us, too. Learn more about the conference, and register, at:

Afib Patients from the US, Canada, and the Caribbean Will Convene in Dallas for the Get in Rhythm, Stay in Rhythm Atrial Fibrillation Patient Conference

FDA gets request to approve Pradaxa reversal agent idarucizumab

Big news! Boehringer Ingelheim has submitted an application to the FDA requesting accelerated approval for idarucizumab, the reversal agent for Pradaxa (dabigatran). See: Boehringer Ingelheim Submits Biologics License Application to FDA for Idarucizumab*, Investigational Specific Reversal Agent for Pradaxa®

Additionally, they have submitted for marketing approval by Health Canada and the European Medicines Agency (EMA). See: Boehringer Ingelheim submits applications for approval of idarucizumab*, specific reversal agent to dabigatran etexilate (Pradaxa®), to EMA, FDA and Health Canada

 

For more information...